In comparison, IDH wild-type gliomas in pediatric or young adult patients are genetically featured with BRAFV600E mutation, fibroblast growth factor receptor 1 (FGFR1) alteration, and a MYB or MYB1 rearrangement [9]. This evidence concerns the gene IDH1 and central nervous system cancer.